Kopp Family Office, LLC Neogenomics Inc Transaction History

Kopp Family Office, LLC

  • $161 Million
  • Q2 2024

A detailed history of Kopp Family Office, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Kopp Family Office, LLC holds 944,775 shares of NEO stock, worth $15.6 Million. This represents 8.13% of its overall portfolio holdings.

Number of Shares
944,775
Previous 894,509 5.62%
Holding current value
$15.6 Million
Previous $14.1 Million 6.81%
% of portfolio
8.13%
Previous 8.03%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024
BUY
$13.01 - $15.77 $653,960 - $792,694
50,266 Added 5.62%
944,775 $13.1 Million
Q1 2024

Jun 17, 2024
SELL
$14.06 - $16.79 $5,624 - $6,716
-400 Reduced 0.04%
894,509 $14.1 Million
Q4 2023

Feb 13, 2024
SELL
$11.67 - $20.73 $1.77 Million - $3.15 Million
-151,730 Reduced 14.5%
894,909 $14.5 Million
Q3 2023

Nov 14, 2023
BUY
$12.15 - $17.85 $504,225 - $740,775
41,500 Added 4.13%
1,046,639 $12.9 Million
Q2 2023

Aug 14, 2023
SELL
$14.1 - $19.83 $4.03 Million - $5.67 Million
-285,880 Reduced 22.14%
1,005,139 $16.2 Million
Q1 2023

May 15, 2023
SELL
$9.09 - $19.45 $2.05 Million - $4.38 Million
-225,294 Reduced 14.86%
1,291,019 $22.5 Million
Q4 2022

Feb 14, 2023
SELL
$6.45 - $12.07 $147,060 - $275,196
-22,800 Reduced 1.48%
1,516,313 $14 Million
Q3 2022

Nov 14, 2022
SELL
$7.86 - $12.91 $600,504 - $986,324
-76,400 Reduced 4.73%
1,539,113 $13.3 Million
Q2 2022

Aug 16, 2022
BUY
$7.06 - $13.97 $8,825 - $17,462
1,250 Added 0.08%
1,615,513 $13.2 Million
Q1 2022

May 16, 2022
BUY
$12.15 - $35.28 $23,085 - $67,032
1,900 Added 0.12%
1,614,263 $19.6 Million
Q4 2021

Feb 15, 2022
SELL
$30.49 - $48.49 $5.28 Million - $8.4 Million
-173,242 Reduced 9.7%
1,612,363 $55 Million
Q3 2021

Nov 16, 2021
SELL
$41.66 - $52.52 $9.9 Million - $12.5 Million
-237,750 Reduced 11.75%
1,785,605 $86.1 Million
Q2 2021

Aug 16, 2021
SELL
$36.62 - $51.69 $6.58 Million - $9.29 Million
-179,810 Reduced 8.16%
2,023,355 $91.4 Million
Q1 2021

May 17, 2021
SELL
$41.56 - $59.88 $36.4 Million - $52.4 Million
-875,650 Reduced 28.44%
2,203,165 $106 Million
Q4 2020

Feb 16, 2021
SELL
$36.08 - $56.47 $5.56 Million - $8.71 Million
-154,200 Reduced 4.77%
3,078,815 $166 Million
Q3 2020

Nov 16, 2020
SELL
$33.26 - $40.48 $47.5 Million - $57.8 Million
-1,428,820 Reduced 30.65%
3,233,015 $119 Million
Q2 2020

Aug 17, 2020
SELL
$24.21 - $31.02 $2.54 Billion - $3.26 Billion
-105,073,410 Reduced 95.75%
4,661,835 $144 Million
Q2 2020

Aug 14, 2020
BUY
$24.21 - $31.02 $2.54 Billion - $3.26 Billion
105,076,410 Added 2255.42%
109,735,245 $144 Million
Q1 2020

May 15, 2020
SELL
$20.5 - $34.53 $3.81 Million - $6.42 Million
-185,790 Reduced 3.83%
4,658,835 $129 Million
Q4 2019

Feb 14, 2020
BUY
$18.96 - $29.84 $91.9 Million - $145 Million
4,844,625 New
4,844,625 $142 Million

Others Institutions Holding NEO

# of Institutions
294
Shares Held
124M
Call Options Held
698K
Put Options Held
120K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.08B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Kopp Family Office, LLC Portfolio

Follow Kopp Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kopp Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kopp Family Office, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email